Rickie Sonpal

Rickie Sonpal

Rickie Sonpal has a broad-based corporate and transactional practice that encompasses mergers and acquisitions, partnerships and joint ventures, debt and equity financing, and general corporate and commercial matters. He is a member of the firm’s Business Transactions and Finance Groups. He is also a member of the firm’s Business Transactions Group.

Subscribe to all posts by Rickie Sonpal

CBD Update: FDA Issues Statement, Calls Public Hearing, and Announces Warning Letters on Products Containing Cannabis and its Components

On April 2, 2019, the Federal Food and Drug Administration (FDA) issued a statement and announced a public hearing on consumer products derived from cannabis and its components, including cannabidiol (CBD). Recognizing the need to provide clarity on the authority of FDA to regulate these products, and what pathways are available for marketing them, the agency outlined its next steps:

  • public hearing will be held on May 31, and written comments are being sought from the public.
  • FDA is forming a high-level internal agency working group to explore potential
LexBlog